Health Care & Life Sciences » Pharmaceuticals | Nissui Pharmaceutical Co. Ltd.

Nissui Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
13,141
11,863
12,015
12,825
12,329
12,549
Cost of Goods Sold (COGS) incl. D&A
6,338
6,024
5,963
6,442
6,476
6,791
Gross Income
6,803
5,839
6,052
6,384
5,853
5,758
SG&A Expense
3,941
3,916
4,053
4,682
4,423
4,435
EBIT
2,844
1,913
1,994
-
1,428
1,313
Unusual Expense
12
50
61
57
3
13
Non Operating Income/Expense
696
1,777
941
910
221
41
Interest Expense
-
-
-
-
-
-
Pretax Income
3,644
3,721
2,916
2,584
1,691
1,382
Income Tax
1,338
1,250
875
681
515
597
Consolidated Net Income
2,306
2,471
2,041
1,903
1,175
784
Net Income
2,306
2,471
2,041
1,903
1,175
784
Net Income After Extraordinaries
2,306
2,471
2,041
1,903
1,175
784
Net Income Available to Common
2,306
2,471
2,041
1,903
1,175
784
EPS (Basic)
102.95
110.33
91.14
84.97
52.47
35.01
Basic Shares Outstanding
22
22
22
22
22
22
EPS (Diluted)
102.95
110.33
91.14
84.97
52.47
35.01
Diluted Shares Outstanding
22
22
22
22
22
22
EBITDA
3,195
2,236
2,334
2,103
1,816
1,693
Other Operating Expense
18
10
5
4
2
10
Non-Operating Interest Income
116
82
43
33
37
41

About Nissui Pharmaceutical Co.

View Profile
Address
Nissuiseiyaku Building
Tokyo Tokyo 110
Japan
Employees -
Website http://www.nissui-pharm.co.jp
Updated 07/08/2019
Nissui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of culture media and diagnostics for medical institutions, research organizations, and food industries. Its operations are carried out through the following segments: Clinical Diagnostics and Pharmaceuticals. The Clinical Diagnostics segment provides reagents and instruments for microbiological and immunological tests, and also quality control materials for human diagnostic use, food sanitation use and biological research in both the public and private organizations.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.